4-54100663-G-C

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_133267.3(GSX2):​c.319G>C​(p.Gly107Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G107S) has been classified as Benign.

Frequency

Genomes: not found (cov: 31)

Consequence

GSX2
NM_133267.3 missense

Scores

2
3
13

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0180

Publications

17 publications found
Variant links:
Genes affected
GSX2 (HGNC:24959): (GS homeobox 2) Enables DNA-binding transcription factor activity, RNA polymerase II-specific and sequence-specific double-stranded DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to act upstream of or within several processes, including nervous system development; positive regulation of Notch signaling pathway; and regulation of respiratory gaseous exchange by nervous system process. Located in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Apr 2022]
GSX2 Gene-Disease associations (from GenCC):
  • diencephalic-mesencephalic junction dysplasia syndrome 2
    Inheritance: Unknown, AR Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.11295506).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_133267.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GSX2
NM_133267.3
MANE Select
c.319G>Cp.Gly107Arg
missense
Exon 1 of 2NP_573574.2Q9BZM3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GSX2
ENST00000326902.7
TSL:1 MANE Select
c.319G>Cp.Gly107Arg
missense
Exon 1 of 2ENSP00000319118.2Q9BZM3
ENSG00000282278
ENST00000507166.5
TSL:2
c.1018-174262G>C
intron
N/AENSP00000423325.1A0A0B4J203
GSX2
ENST00000503800.1
TSL:5
c.319G>Cp.Gly107Arg
missense
Exon 1 of 2ENSP00000422213.1D6R903

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD4 exome
Cov.:
64
GnomAD4 genome
Cov.:
31

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.53
BayesDel_addAF
Benign
-0.058
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
19
DANN
Uncertain
0.98
DEOGEN2
Benign
0.17
T
Eigen
Benign
-0.85
Eigen_PC
Benign
-0.72
FATHMM_MKL
Benign
0.49
N
LIST_S2
Benign
0.53
T
M_CAP
Pathogenic
0.47
D
MetaRNN
Benign
0.11
T
MetaSVM
Benign
-0.71
T
MutationAssessor
Benign
1.4
L
PhyloP100
-0.018
PrimateAI
Pathogenic
0.84
D
PROVEAN
Benign
-0.21
N
REVEL
Benign
0.11
Sift
Uncertain
0.020
D
Sift4G
Benign
0.090
T
Polyphen
0.0
B
Vest4
0.13
MutPred
0.32
Loss of glycosylation at S111 (P = 0.0297)
MVP
0.61
MPC
1.1
ClinPred
0.62
D
GERP RS
1.4
PromoterAI
-0.015
Neutral
Varity_R
0.073
gMVP
0.39
Mutation Taster
=87/13
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13144341; hg19: chr4-54966830; API